Global and United States Ergotamine Market Report & Forecast 2023-2028

Report ID: 1828620 | Published Date: Jan 2025 | No. of Page: 98 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Ergotamine Product Introduction
    1.2 Global Ergotamine Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Ergotamine Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Ergotamine Sales in Volume for the Year 2017-2028
    1.3 United States Ergotamine Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Ergotamine Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Ergotamine Sales in Volume for the Year 2017-2028
    1.4 Ergotamine Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Ergotamine in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Ergotamine Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Ergotamine Market Dynamics
        1.5.1 Ergotamine Industry Trends
        1.5.2 Ergotamine Market Drivers
        1.5.3 Ergotamine Market Challenges
        1.5.4 Ergotamine Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Ergotamine Market Segment by Type
        2.1.1 Ergotamine Tartrate
        2.1.2 Dichloroergotamine
        2.1.3 Ergotamine Caffeine
    2.2 Global Ergotamine Market Size by Type
        2.2.1 Global Ergotamine Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Ergotamine Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Ergotamine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Ergotamine Market Size by Type
        2.3.1 United States Ergotamine Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Ergotamine Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Ergotamine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Ergotamine Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Clinics
        3.1.3 Others
    3.2 Global Ergotamine Market Size by Application
        3.2.1 Global Ergotamine Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Ergotamine Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Ergotamine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Ergotamine Market Size by Application
        3.3.1 United States Ergotamine Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Ergotamine Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Ergotamine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Ergotamine Competitor Landscape by Company
    4.1 Global Ergotamine Market Size by Company
        4.1.1 Top Global Ergotamine Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Ergotamine Revenue by Manufacturer (2017-2022)
        4.1.3 Global Ergotamine Sales by Manufacturer (2017-2022)
        4.1.4 Global Ergotamine Price by Manufacturer (2017-2022)
    4.2 Global Ergotamine Concentration Ratio (CR)
        4.2.1 Ergotamine Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Ergotamine in 2021
        4.2.3 Global Ergotamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Ergotamine Manufacturing Base Distribution, Product Type
        4.3.1 Global Ergotamine Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Ergotamine Product Type
        4.3.3 Date of International Manufacturers Enter into Ergotamine Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Ergotamine Market Size by Company
        4.5.1 Top Ergotamine Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Ergotamine Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Ergotamine Sales by Players (2020, 2021 & 2022)
5 Global Ergotamine Market Size by Region
    5.1 Global Ergotamine Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Ergotamine Market Size in Volume by Region (2017-2028)
        5.2.1 Global Ergotamine Sales in Volume by Region: 2017-2022
        5.2.2 Global Ergotamine Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Ergotamine Market Size in Value by Region (2017-2028)
        5.3.1 Global Ergotamine Sales in Value by Region: 2017-2022
        5.3.2 Global Ergotamine Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Ergotamine Market Size YoY Growth 2017-2028
        6.1.2 North America Ergotamine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Ergotamine Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Ergotamine Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Ergotamine Market Size YoY Growth 2017-2028
        6.3.2 Europe Ergotamine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Ergotamine Market Size YoY Growth 2017-2028
        6.4.2 Latin America Ergotamine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Ergotamine Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Ergotamine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 Sanofi
        7.1.1 Sanofi Corporation Information
        7.1.2 Sanofi Description and Business Overview
        7.1.3 Sanofi Ergotamine Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Sanofi Ergotamine Products Offered
        7.1.5 Sanofi Recent Development
    7.2 3M
        7.2.1 3M Corporation Information
        7.2.2 3M Description and Business Overview
        7.2.3 3M Ergotamine Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 3M Ergotamine Products Offered
        7.2.5 3M Recent Development
    7.3 AstraZeneca
        7.3.1 AstraZeneca Corporation Information
        7.3.2 AstraZeneca Description and Business Overview
        7.3.3 AstraZeneca Ergotamine Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 AstraZeneca Ergotamine Products Offered
        7.3.5 AstraZeneca Recent Development
    7.4 Novartis
        7.4.1 Novartis Corporation Information
        7.4.2 Novartis Description and Business Overview
        7.4.3 Novartis Ergotamine Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Novartis Ergotamine Products Offered
        7.4.5 Novartis Recent Development
    7.5 Pfizer
        7.5.1 Pfizer Corporation Information
        7.5.2 Pfizer Description and Business Overview
        7.5.3 Pfizer Ergotamine Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Pfizer Ergotamine Products Offered
        7.5.5 Pfizer Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Ergotamine Industry Chain Analysis
    8.2 Ergotamine Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Ergotamine Distributors
    8.3 Ergotamine Production Mode & Process
    8.4 Ergotamine Sales and Marketing
        8.4.1 Ergotamine Sales Channels
        8.4.2 Ergotamine Distributors
    8.5 Ergotamine Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Ergotamine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Ergotamine Market Trends
    Table 3. Ergotamine Market Drivers
    Table 4. Ergotamine Market Challenges
    Table 5. Ergotamine Market Restraints
    Table 6. Global Ergotamine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Ergotamine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Ergotamine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Ergotamine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Ergotamine Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Ergotamine Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Ergotamine Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Ergotamine Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Ergotamine Sales Share by Manufacturer, 2017-2022
    Table 15. Global Ergotamine Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Ergotamine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Ergotamine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ergotamine as of 2021)
    Table 18. Top Players of Ergotamine in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Ergotamine Product Type
    Table 20. Date of International Manufacturers Enter into Ergotamine Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Ergotamine Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Ergotamine Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Ergotamine Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Ergotamine Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Ergotamine Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Ergotamine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Ergotamine Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Ergotamine Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Ergotamine Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Ergotamine Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Ergotamine Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Ergotamine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Ergotamine Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Ergotamine Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Ergotamine Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Ergotamine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Ergotamine Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Ergotamine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Ergotamine Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Ergotamine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Sanofi Corporation Information
    Table 43. Sanofi Description and Business Overview
    Table 44. Sanofi Ergotamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. Sanofi Ergotamine Product
    Table 46. Sanofi Recent Development
    Table 47. 3M Corporation Information
    Table 48. 3M Description and Business Overview
    Table 49. 3M Ergotamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. 3M Product
    Table 51. 3M Recent Development
    Table 52. AstraZeneca Corporation Information
    Table 53. AstraZeneca Description and Business Overview
    Table 54. AstraZeneca Ergotamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. AstraZeneca Product
    Table 56. AstraZeneca Recent Development
    Table 57. Novartis Corporation Information
    Table 58. Novartis Description and Business Overview
    Table 59. Novartis Ergotamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Novartis Product
    Table 61. Novartis Recent Development
    Table 62. Pfizer Corporation Information
    Table 63. Pfizer Description and Business Overview
    Table 64. Pfizer Ergotamine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. Pfizer Product
    Table 66. Pfizer Recent Development
    Table 67. Key Raw Materials Lists
    Table 68. Raw Materials Key Suppliers Lists
    Table 69. Ergotamine Customers List
    Table 70. Ergotamine Distributors List
    Table 71. Research Programs/Design for This Report
    Table 72. Key Data Information from Secondary Sources
    Table 73. Key Data Information from Primary Sources
List of Figures
    Figure 1. Ergotamine Product Picture
    Figure 2. Global Ergotamine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Ergotamine Market Size 2017-2028 (US$ Million)
    Figure 4. Global Ergotamine Sales 2017-2028 (K Units)
    Figure 5. United States Ergotamine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Ergotamine Market Size 2017-2028 (US$ Million)
    Figure 7. United States Ergotamine Sales 2017-2028 (K Units)
    Figure 8. United States Ergotamine Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Ergotamine Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Ergotamine Report Years Considered
    Figure 11. Product Picture of Ergotamine Tartrate
    Figure 12. Product Picture of Dichloroergotamine
    Figure 13. Product Picture of Ergotamine Caffeine
    Figure 14. Global Ergotamine Market Share by Type in 2022 & 2028
    Figure 15. Global Ergotamine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Ergotamine Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Ergotamine Sales by Type (2017-2028) & (K Units)
    Figure 18. Global Ergotamine Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Ergotamine Price by Type (2017-2028) & (US$/Unit)
    Figure 20. United States Ergotamine Market Share by Type in 2022 & 2028
    Figure 21. United States Ergotamine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Ergotamine Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Ergotamine Sales by Type (2017-2028) & (K Units)
    Figure 24. United States Ergotamine Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Ergotamine Price by Type (2017-2028) & (US$/Unit)
    Figure 26. Product Picture of Hospitals
    Figure 27. Product Picture of Clinics
    Figure 28. Product Picture of Others
    Figure 29. Global Ergotamine Market Share by Application in 2022 & 2028
    Figure 30. Global Ergotamine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Ergotamine Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Ergotamine Sales by Application (2017-2028) & (K Units)
    Figure 33. Global Ergotamine Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Ergotamine Price by Application (2017-2028) & (US$/Unit)
    Figure 35. United States Ergotamine Market Share by Application in 2022 & 2028
    Figure 36. United States Ergotamine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Ergotamine Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Ergotamine Sales by Application (2017-2028) & (K Units)
    Figure 39. United States Ergotamine Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Ergotamine Price by Application (2017-2028) & (US$/Unit)
    Figure 41. North America Ergotamine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 42. North America Ergotamine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Ergotamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Ergotamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Ergotamine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 46. Europe Ergotamine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Ergotamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Ergotamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Ergotamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Ergotamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Ergotamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Ergotamine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 53. Asia-Pacific Ergotamine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Ergotamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Ergotamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Ergotamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Ergotamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Ergotamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan Ergotamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Ergotamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Ergotamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Ergotamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines Ergotamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Ergotamine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 65. Latin America Ergotamine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Ergotamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Ergotamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Ergotamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Ergotamine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 70. Middle East & Africa Ergotamine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Ergotamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Ergotamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. UAE Ergotamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Ergotamine Value Chain
    Figure 75. Ergotamine Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi
3M
AstraZeneca
Novartis
Pfizer
Frequently Asked Questions
Ergotamine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Ergotamine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Ergotamine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Zolmitriptan

Zolmitriptan market is segmented by region (country), players, by Type and by Application. Player ... Read More